Efectos del uso del 17 β-estradiol y la genisteína en la enfermedad de Alzheimer en mujeres con menopausia |
| |
Authors: | Cristina Chávez-Pérez Araceli Ceballos-Ramírez Abel Suárez-Castro |
| |
Institution: | 1. Facultad en Ciencias de la Nutrición, Universidad de Morelia, Morelia, Michoacán, México;2. Laboratorio de Diseño Molecular, Instituto de Investigaciones Químico-Biológicas, Universidad Michoacana de San Nicolás de Hidalgo, Morelia, Michoacán, México |
| |
Abstract: | The use of 17 β-estradiol and genistein in women with menopause helps in the reduction of vasomotor symptoms and cognitive improvement. There is evidence on the use of certain flavonoids such as genistein, which has a potentially neuroprotective role in neurodegenerative diseases such as Alzheimer's. Scientific evidence on the effects of phytoestrogens and genistein during menopause and their effect on cognition are scarce, however, in the present review it was found that the intervention with 17 β-estradiol has positive effects on cognition in women with Alzheimer's disease. In addition, the use of genistein, daidzein or any supplement based on isoflavones may influence vasomotor symptoms. 17 β-estradiol supplements in women in early menopause and with some degree of cognitive impairment may have beneficial effects. |
| |
Keywords: | 17 β-estradiol Genistein Menopause Alzheimer's disease |
本文献已被 ScienceDirect 等数据库收录! |
|